NCT04899765View on ClinicalTrials.gov

Measles and BCG Vaccines for Mother and Child

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Vaccine Preventable DiseaseMeaslesMother-Infant InteractionBCG Vaccination Reaction
Interventions
BIOLOGICAL

BCG vaccine

It is an attenuated live bacterial vaccine. This vaccine is a freeze-dried product that must be reconstituted.

BIOLOGICAL

Measles vaccine

It is an attenuated live virus vaccine. This vaccine is a freeze-dried product that must be reconstituted.

OTHER

Placebo

Saline

Trial Locations (1)

1004

RECRUITING

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

The University of Western Australia

OTHER

collaborator

Université Libre de Bruxelles

OTHER

lead

Bandim Health Project

OTHER